Report cover image

Global Enalaprilat Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 196 Pages
SKU # APRC20360370

Description

Summary

According to APO Research, the global Enalaprilat market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Enalaprilat is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Enalaprilat is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Enalaprilat market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Enalaprilat is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Enalaprilat market include Balkan Pharmaceuticals, Cadila Pharmaceuticals, Hikma Pharmaceuticals, KRKA, Novartis(Hexal AG), SteriMax and Teva(Barr Pharmaceuticals), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Enalaprilat, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Enalaprilat, also provides the sales of main regions and countries. Of the upcoming market potential for Enalaprilat, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Enalaprilat sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Enalaprilat market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Enalaprilat sales, projected growth trends, production technology, application and end-user industry.

Enalaprilat Segment by Company

Balkan Pharmaceuticals
Cadila Pharmaceuticals
Hikma Pharmaceuticals
KRKA
Novartis(Hexal AG)
SteriMax
Teva(Barr Pharmaceuticals)
Enalaprilat Segment by Type

1mL Vial
2mL Vial
Enalaprilat Segment by Application

Hospital
Pharmacy
Enalaprilat Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Enalaprilat status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Enalaprilat market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Enalaprilat significant trends, drivers, influence factors in global and regions.
6. To analyze Enalaprilat competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enalaprilat market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enalaprilat and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enalaprilat.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Enalaprilat market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Enalaprilat industry.
Chapter 3: Detailed analysis of Enalaprilat manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Enalaprilat in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Enalaprilat in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Enalaprilat Sales Value (2020-2031)
1.2.2 Global Enalaprilat Sales Volume (2020-2031)
1.2.3 Global Enalaprilat Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Enalaprilat Market Dynamics
2.1 Enalaprilat Industry Trends
2.2 Enalaprilat Industry Drivers
2.3 Enalaprilat Industry Opportunities and Challenges
2.4 Enalaprilat Industry Restraints
3 Enalaprilat Market by Company
3.1 Global Enalaprilat Company Revenue Ranking in 2024
3.2 Global Enalaprilat Revenue by Company (2020-2025)
3.3 Global Enalaprilat Sales Volume by Company (2020-2025)
3.4 Global Enalaprilat Average Price by Company (2020-2025)
3.5 Global Enalaprilat Company Ranking (2023-2025)
3.6 Global Enalaprilat Company Manufacturing Base and Headquarters
3.7 Global Enalaprilat Company Product Type and Application
3.8 Global Enalaprilat Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Enalaprilat Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Enalaprilat Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Enalaprilat Market by Type
4.1 Enalaprilat Type Introduction
4.1.1 1mL Vial
4.1.2 2mL Vial
4.2 Global Enalaprilat Sales Volume by Type
4.2.1 Global Enalaprilat Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Enalaprilat Sales Volume by Type (2020-2031)
4.2.3 Global Enalaprilat Sales Volume Share by Type (2020-2031)
4.3 Global Enalaprilat Sales Value by Type
4.3.1 Global Enalaprilat Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Enalaprilat Sales Value by Type (2020-2031)
4.3.3 Global Enalaprilat Sales Value Share by Type (2020-2031)
5 Enalaprilat Market by Application
5.1 Enalaprilat Application Introduction
5.1.1 Hospital
5.1.2 Pharmacy
5.2 Global Enalaprilat Sales Volume by Application
5.2.1 Global Enalaprilat Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Enalaprilat Sales Volume by Application (2020-2031)
5.2.3 Global Enalaprilat Sales Volume Share by Application (2020-2031)
5.3 Global Enalaprilat Sales Value by Application
5.3.1 Global Enalaprilat Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Enalaprilat Sales Value by Application (2020-2031)
5.3.3 Global Enalaprilat Sales Value Share by Application (2020-2031)
6 Enalaprilat Regional Sales and Value Analysis
6.1 Global Enalaprilat Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Enalaprilat Sales by Region (2020-2031)
6.2.1 Global Enalaprilat Sales by Region: 2020-2025
6.2.2 Global Enalaprilat Sales by Region (2026-2031)
6.3 Global Enalaprilat Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Enalaprilat Sales Value by Region (2020-2031)
6.4.1 Global Enalaprilat Sales Value by Region: 2020-2025
6.4.2 Global Enalaprilat Sales Value by Region (2026-2031)
6.5 Global Enalaprilat Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Enalaprilat Sales Value (2020-2031)
6.6.2 North America Enalaprilat Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Enalaprilat Sales Value (2020-2031)
6.7.2 Europe Enalaprilat Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Enalaprilat Sales Value (2020-2031)
6.8.2 Asia-Pacific Enalaprilat Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Enalaprilat Sales Value (2020-2031)
6.9.2 South America Enalaprilat Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Enalaprilat Sales Value (2020-2031)
6.10.2 Middle East & Africa Enalaprilat Sales Value Share by Country, 2024 VS 2031
7 Enalaprilat Country-level Sales and Value Analysis
7.1 Global Enalaprilat Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Enalaprilat Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Enalaprilat Sales by Country (2020-2031)
7.3.1 Global Enalaprilat Sales by Country (2020-2025)
7.3.2 Global Enalaprilat Sales by Country (2026-2031)
7.4 Global Enalaprilat Sales Value by Country (2020-2031)
7.4.1 Global Enalaprilat Sales Value by Country (2020-2025)
7.4.2 Global Enalaprilat Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Enalaprilat Sales Value Growth Rate (2020-2031)
7.5.2 USA Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Enalaprilat Sales Value Growth Rate (2020-2031)
7.6.2 Canada Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Enalaprilat Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Enalaprilat Sales Value Growth Rate (2020-2031)
7.8.2 Germany Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Enalaprilat Sales Value Growth Rate (2020-2031)
7.9.2 France Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.9.3 France Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Enalaprilat Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Enalaprilat Sales Value Growth Rate (2020-2031)
7.11.2 Italy Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Enalaprilat Sales Value Growth Rate (2020-2031)
7.12.2 Spain Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Enalaprilat Sales Value Growth Rate (2020-2031)
7.13.2 Russia Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Enalaprilat Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Enalaprilat Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Enalaprilat Sales Value Growth Rate (2020-2031)
7.16.2 China Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.16.3 China Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Enalaprilat Sales Value Growth Rate (2020-2031)
7.17.2 Japan Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Enalaprilat Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Enalaprilat Sales Value Growth Rate (2020-2031)
7.19.2 India Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.19.3 India Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Enalaprilat Sales Value Growth Rate (2020-2031)
7.20.2 Australia Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Enalaprilat Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Enalaprilat Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Enalaprilat Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Enalaprilat Sales Value Growth Rate (2020-2031)
7.24.2 Chile Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Enalaprilat Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Enalaprilat Sales Value Growth Rate (2020-2031)
7.26.2 Peru Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Enalaprilat Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Enalaprilat Sales Value Growth Rate (2020-2031)
7.28.2 Israel Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Enalaprilat Sales Value Growth Rate (2020-2031)
7.29.2 UAE Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Enalaprilat Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Enalaprilat Sales Value Growth Rate (2020-2031)
7.31.2 Iran Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Enalaprilat Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Enalaprilat Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Enalaprilat Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Enalaprilat Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Balkan Pharmaceuticals
8.1.1 Balkan Pharmaceuticals Comapny Information
8.1.2 Balkan Pharmaceuticals Business Overview
8.1.3 Balkan Pharmaceuticals Enalaprilat Sales, Value and Gross Margin (2020-2025)
8.1.4 Balkan Pharmaceuticals Enalaprilat Product Portfolio
8.1.5 Balkan Pharmaceuticals Recent Developments
8.2 Cadila Pharmaceuticals
8.2.1 Cadila Pharmaceuticals Comapny Information
8.2.2 Cadila Pharmaceuticals Business Overview
8.2.3 Cadila Pharmaceuticals Enalaprilat Sales, Value and Gross Margin (2020-2025)
8.2.4 Cadila Pharmaceuticals Enalaprilat Product Portfolio
8.2.5 Cadila Pharmaceuticals Recent Developments
8.3 Hikma Pharmaceuticals
8.3.1 Hikma Pharmaceuticals Comapny Information
8.3.2 Hikma Pharmaceuticals Business Overview
8.3.3 Hikma Pharmaceuticals Enalaprilat Sales, Value and Gross Margin (2020-2025)
8.3.4 Hikma Pharmaceuticals Enalaprilat Product Portfolio
8.3.5 Hikma Pharmaceuticals Recent Developments
8.4 KRKA
8.4.1 KRKA Comapny Information
8.4.2 KRKA Business Overview
8.4.3 KRKA Enalaprilat Sales, Value and Gross Margin (2020-2025)
8.4.4 KRKA Enalaprilat Product Portfolio
8.4.5 KRKA Recent Developments
8.5 Novartis(Hexal AG)
8.5.1 Novartis(Hexal AG) Comapny Information
8.5.2 Novartis(Hexal AG) Business Overview
8.5.3 Novartis(Hexal AG) Enalaprilat Sales, Value and Gross Margin (2020-2025)
8.5.4 Novartis(Hexal AG) Enalaprilat Product Portfolio
8.5.5 Novartis(Hexal AG) Recent Developments
8.6 SteriMax
8.6.1 SteriMax Comapny Information
8.6.2 SteriMax Business Overview
8.6.3 SteriMax Enalaprilat Sales, Value and Gross Margin (2020-2025)
8.6.4 SteriMax Enalaprilat Product Portfolio
8.6.5 SteriMax Recent Developments
8.7 Teva(Barr Pharmaceuticals)
8.7.1 Teva(Barr Pharmaceuticals) Comapny Information
8.7.2 Teva(Barr Pharmaceuticals) Business Overview
8.7.3 Teva(Barr Pharmaceuticals) Enalaprilat Sales, Value and Gross Margin (2020-2025)
8.7.4 Teva(Barr Pharmaceuticals) Enalaprilat Product Portfolio
8.7.5 Teva(Barr Pharmaceuticals) Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Enalaprilat Value Chain Analysis
9.1.1 Enalaprilat Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Enalaprilat Sales Mode & Process
9.2 Enalaprilat Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Enalaprilat Distributors
9.2.3 Enalaprilat Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.